Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taral Patel

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Oncology and Therapy|July 7, 2017
Efficacy and Safety Results of the Afatinib Expanded Access ProgramEdward S Kim, Balazs Halmos, Ingrid F Kohut, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2010
Cetuximab and first-line taxane/carboplatin chemotherapy in advanced non-small-cell lung cancer: results of the randomized multicenter phase III trial BMS099Thomas J Lynch, Taral Patel, Luke Dreisbach, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 15, 2014
Biomarker analyses from a randomized, placebo-controlled, phase IIIb trial comparing bevacizumab with or without erlotinib as maintenance therapy for the treatment of advanced non-small-cell lung cancer (ATLAS)Fairooz Kabbinavar, Louis Fehrenbacher, John Hainsworth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 5, 2008
Randomized phase II adjuvant trial of dose-dense docetaxel before or after doxorubicin plus cyclophosphamide in axillary node-positive breast cancerShannon Puhalla, Ewa Mrozek, Donn Young, et al.
Coronary Artery Disease|December 4, 2008
Stress-induced ST-segment deviation in relation to the presence and severity of coronary artery disease in patients with normal myocardial perfusion imagingJonathan W Weinsaft, Shant J Manoushagian, Taral Patel, et al.
Journal of Cardiovascular Electrophysiology|June 16, 2012
Prevalence and predictors of cable extrusion and loss of electrical integrity with the Riata defibrillator leadSharon Shen, Prashant Bhave, Evan Giedrimas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 9, 2013
ATLAS: randomized, double-blind, placebo-controlled, phase IIIB trial comparing bevacizumab therapy with or without erlotinib, after completion of chemotherapy, with bevacizumab for first-line treatment of advanced non-small-cell lung cancerBruce E Johnson, Fairooz Kabbinavar, Louis Fehrenbacher, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|March 10, 2025
Novel Mechanical Aspiration Thrombectomy in Patients With Acute Pulmonary Embolism: Results From the Prospective APEX-AV TrialMona Ranade, Malcolm T Foster, Paul S Brady, et al.
Future Oncology (London, England)|June 30, 2026
Real-world comparative effectiveness of first-line BTK inhibitors in chronic lymphocytic leukemiaJing-Zhou Hou, Rushir Choksi, Gregory A Maglinte, et al.
Anti-Cancer Drugs|August 24, 2013
Absence of pharmacokinetic drug-drug interaction of pertuzumab with trastuzumab and docetaxelJavier Cortés, Sandra M Swain, Iveta Kudaba, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Oncology and Therapy|July 7, 2017
Efficacy and Safety Results of the Afatinib Expanded Access ProgramEdward S Kim, Balazs Halmos, Ingrid F Kohut, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2010
Cetuximab and first-line taxane/carboplatin chemotherapy in advanced non-small-cell lung cancer: results of the randomized multicenter phase III trial BMS099Thomas J Lynch, Taral Patel, Luke Dreisbach, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 15, 2014
Biomarker analyses from a randomized, placebo-controlled, phase IIIb trial comparing bevacizumab with or without erlotinib as maintenance therapy for the treatment of advanced non-small-cell lung cancer (ATLAS)Fairooz Kabbinavar, Louis Fehrenbacher, John Hainsworth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 5, 2008
Randomized phase II adjuvant trial of dose-dense docetaxel before or after doxorubicin plus cyclophosphamide in axillary node-positive breast cancerShannon Puhalla, Ewa Mrozek, Donn Young, et al.
Coronary Artery Disease|December 4, 2008
Stress-induced ST-segment deviation in relation to the presence and severity of coronary artery disease in patients with normal myocardial perfusion imagingJonathan W Weinsaft, Shant J Manoushagian, Taral Patel, et al.
Journal of Cardiovascular Electrophysiology|June 16, 2012
Prevalence and predictors of cable extrusion and loss of electrical integrity with the Riata defibrillator leadSharon Shen, Prashant Bhave, Evan Giedrimas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 9, 2013
ATLAS: randomized, double-blind, placebo-controlled, phase IIIB trial comparing bevacizumab therapy with or without erlotinib, after completion of chemotherapy, with bevacizumab for first-line treatment of advanced non-small-cell lung cancerBruce E Johnson, Fairooz Kabbinavar, Louis Fehrenbacher, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|March 10, 2025
Novel Mechanical Aspiration Thrombectomy in Patients With Acute Pulmonary Embolism: Results From the Prospective APEX-AV TrialMona Ranade, Malcolm T Foster, Paul S Brady, et al.
Future Oncology (London, England)|June 30, 2026
Real-world comparative effectiveness of first-line BTK inhibitors in chronic lymphocytic leukemiaJing-Zhou Hou, Rushir Choksi, Gregory A Maglinte, et al.
Anti-Cancer Drugs|August 24, 2013
Absence of pharmacokinetic drug-drug interaction of pertuzumab with trastuzumab and docetaxelJavier Cortés, Sandra M Swain, Iveta Kudaba, et al.
Pageof 5